Kuwait Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
October 22, 2014
122 Pages - SKU: BMI5361535
Countries covered: Kuwait

Kuwait Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Notwithstanding a recent escalation in political uncertainty, Kuwait's healthcare sector isforecast to preserve its trajectory of modest growth throughout the remainder of 2014. Rising sales areunderpinned by an expanding population, whose levels of chronic conditions increasingly call for thesupply of long-term treatments and cutting-edge medical equipment. In addition, apprehension towards fakegenerics and an accompanying government crackdown have further solidified popular demand for brandeddrugs. However, a confusing bureaucracy and sluggish implementation of key foreign direct investment andintellectual property reform will continue to dampen overall investment and restrain Kuwait from matchingthe pace of other emerging economies.

Headline Expenditure Projections

Pharmaceuticals: KWD290mn (USD1.02bn) in 2013 to KWD306mn (USD1.10bn) in 2014; +5.6% inlocal currency terms and +7.6% in US dollar terms. Forecast unchanged from Q3 2014.

Healthcare: KWD1.43bn (USD5.03bn) in 2013 to KWD1.56bn (USD5.58bn) in 2014; +8.8% in localcurrency terms and +10.8% in US dollar terms. Forecast unchanged from Q3 2014.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Kuwait Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Kuwait - Q3 2014 by Business Monitor International
Kuwait Pharmaceuticals and Healthcare Report Q3 2014BMI View: Despite upcoming by-elections, Kuwait's economy is forecast to post moderate growth in 2014,and the prospects for consumption ...
Kuwait Pharmaceuticals and Healthcare Report Q2 2014 by Business Monitor International
Kuwait Pharmaceuticals and Healthcare Report Q2 2014BMI View: With the Kuwaiti government's continued commitment to austerity, spending on healthcareprovision for expatriate workers (which forms nearly ...
KUWAIT Healthcare & Pharmaceuticals 2013 by Noozz Research
KUWAIT Healthcare & Pharmaceuticals 2013Kuwait’s healthcare and pharmaceutical industries, which are dominated by high levels of government expenditure, and a robust, free public healthcare service ...
See all reports like this >>

More Kuwait reports

D&B Country Report: Kuwait by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!